Home
/
NovaBay Pharmaceuticals, Inc. (NBY)
NovaBay Pharmaceuticals, Inc. (NBY) Technical Analysis
Updated: 2026-03-17 00:39 UTC · Last close: 1.45 (+19.83%)
NovaBay Pharmaceuticals, Inc. (NBY) technical analysis page covering price structure, support and resistance, momentum conditions and a fundamentals snapshot from WOI Scanner.
NovaBay Pharmaceuticals, Inc. (NBY) finished the session at 1.45 (+19.83%). With price below both the 50-day and 200-day moving averages, the broader structure still reflects elevated technical pressure. 20-day momentum is notably weak at -44.23%; price is trading in the lower part of its roughly 52-week range (1.21–95.80); and ATR14 volatility is elevated at roughly 15.96% of price. RSI(14) stands around 35.1, which keeps the momentum picture broadly balanced. RSI has been trending higher in recent sessions, indicating improving momentum conditions. MACD is positioned above the signal line, supporting a still constructive momentum backdrop. The MACD histogram remains positive, although upside momentum is not accelerating further. Recent trading volume is running well above its 20-day average, which suggests strong participation behind the latest price moves. On the upside, 9.29 is the nearest resistance area. A cleaner push through that zone would improve continuation potential. On the fundamentals side, the latest snapshot shows Revenue: 46,000 · Net income: 4.46M · EPS (basic): 0.78. For a fuller technical read, the interactive view adds overlays, pattern context and broader chart structure.
Fundamentals Snapshot
Source: sec
Company
NovaBay Pharmaceuticals, Inc.
Note: This is an algorithmic technical snapshot (not financial advice).